Form 4: Guardant Health's Co-CEO Helmy Eltoukhy Reports Stock Transactions
SEC Form 4 Filing
Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On March 14, 2025, Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., reported transactions involving the company's stock.
- 68,769 shares of common stock were acquired through the vesting of performance-based restricted stock units.
- 34,853 shares were then disposed of to cover tax withholding obligations at a price of $42.89 per share.
- Following these transactions, Eltoukhy directly owns 2,395,081 shares of Guardant Health common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of stock transactions: vesting of restricted stock units and tax withholding. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.